Cytosorbents Corp Stock OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Financials (USD)
Sales 2024 * | 40.31M | Sales 2025 * | 47.76M | Capitalization | 43.77M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -9M | EV / Sales 2024 * | 1.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-2.24
x | P/E ratio 2025 * |
-3.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.62% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
1st Jan change | Capi. | |
---|---|---|
+8.69% | 219B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.72% | 52.02B | |
+3.96% | 48.2B | |
+0.40% | 40.37B | |
+15.03% | 39.35B |